Refine by
Applications
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Diagnostic Solutions for Lung Cancer
- Liquid Biopsy Solutions for Breast Cancer
- Diagnostic Solutions for Colorectal Cancer
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- microbiota for Clinical Studies
- Actionable Molecular Diagnostic System for Physicians
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
Tumor Cell Equipment & Supplies
1,304 equipment items found
Manufactured by:Brenus Pharma based inIssoire, FRANCE
An allogeneic first in class immunotherapy harnessing the patient immune system to fight immune tolerance and prevent cancer ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno CTC ver.3 allow high throughput and more accurate separation of CTCs from whole blood. ...
Manufactured by:Fate Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
MICA and MICB (MICA/B) are stress proteins expressed on a broad range of solid and hematopoietic tumor cells and serve as an activation signal for NKG2D+ NK and T cells. However, MICA/B are frequently shed as an immune escape mechanism, preventing recognition and destruction of tumor cells by the immune system. ...
Manufactured by:Creatv MicroTech, Inc. based inRockville, MARYLAND (USA)
Personalized Cancer Therapy and Disease Monitoring: “Liquid biopsy” using circulating tumor cells (CTCs) is potentially a minimally invasive alternative to traditional tissue biopsy to determine cancer therapy. Enumeration of CTCs may be used to indicate prognosis and to monitor treatment. Isolation of CTCs by size exclusion is a widely researched ...
Manufactured by:Rarecells Diagnostics SAS based inParis Cedex 06, FRANCE
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority of leukocytes. ISET system successfully captures CTCs that are presenting, by definition, heterogeneous phenotypic ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
Pinaka™ is an advanced non-invasive blood test which provides therapeutically relevant information via a safe, simple and quick blood draw. Pinaka™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Pinaka™ ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. ...
Manufactured by:IMG Pharma Biotech S.L. based inDerio - Bizkaia, SPAIN
Pack of 1 slide containing human cell membranes isolated from primary cells, tumor cell lines and biopsies. A collection of human cell membranes isolated from primary cells, tumor cell lines and biopsies. ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells ...
by:Fusix Biotech based inMünchen, GERMANY
As multi-mechanistic antitumor agents, oncolytic viruses are emerging to be potent immunotherapeutic treatment options in different tumor indications. Oncoytic viruses specifically replicate in tumor cells due to altered signalling pathways supporting the tumor’s immune esape, leaving open replication advantages for ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
This drug combines the advantages of two factors: target specificity, which is a characteristic of an antibody, and cytotoxicity, which is a characteristic of a drug. Specifically, this is a technology focused on targeting and killing cancer cells by delivering drugs that cause cytotoxicity to tumor cells using antibodies that can bind to cancer ...
Manufactured by:Beijing Challen Biotechnology Co., Ltd. based inDaxing District, CHINA
Scope of application: Detect the expression of CD3 in human biological specimens and provide doctors with auxiliary information for diagnosis. Testable items: detection of lymphocyte subpopulations, regulatory T cells, PD-1, expressed in blast cells of acute T-ceii leukemia and tumor cells of mature T-ceii ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our ADP-A2M10 (MAGE-A10) T-cell therapy is directed to a member of the MAGE family of cancer testis antigens expressed in a number of solid tumor cell types. Any expression in cancer is often associated with higher grade tumors. Please note that the two trials with ADP-A2M10 are now closed for ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that Bria-IMT™/Bria-OTS™, exert their action by stimulating the antigen-presentation system (i.e. the system ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our ADP-A2M4 (MAGE-A4) SPEAR T-cell therapy is directed to a member of the MAGE family of cancer testis antigen expressed in a number of solid tumor cell types. The MAGE- A4 antigen is among the most commonly expressed cancer-testis antigens. We are conducting various trials with the ADP-A2M4 SPEAR T-cell in various solid ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in industry and research area. We provide Z-DEVD-FMK. Z-DEVD-FMK is a cell-permeable, irreversible inhibitor of Caspase-3/CPP32. It is also an irreversible inhibitor of Caspase-6, Caspase-7, caspase-8, and Caspase-10. Z-DEVD-FMK has been shown to ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib hydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib hydrochloride ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 combines the unique design of zanidatamab with a proprietary cytotoxin and cleavable linker. ZW49 delivers a novel auristatin (cell-killing compound) to tumor cells by taking advantage of the enhanced antibody-HER2 internalization of zanidatamab. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib (ZD 1839) dihydrochloride is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib dihydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib dihydrochloride also ...